Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.65 HKD | +5.37% | +3.24% | -78.63% |
05-10 | Sirnaomics Ltd. Appoints Edward Yongxiang Wang as Executive Director | CI |
04-17 | Sirnaomics Receives US FDA Guidance on Trials for Squamous Cell Carcinoma Treatment | MT |
Evolution of the average Target Price on Sirnaomics Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sirnaomics Ltd.
Nomura |
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2257 Stock
- Consensus Sirnaomics Ltd.